ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition
Kathryn G. Roberts(St. Jude Children's Research Hospital), Charles G. Mullighan(St. Jude Children's Research Hospital), Yaqi Zhao(St. Jude Children's Research Hospital), Aman Seth, David Finkelstein(St. Jude Children's Research Hospital), Kevin Ebata(Memorial Sloan Kettering Cancer Center), Laura J. Janke(St. Jude Children's Research Hospital), Jing Ma, Stephen P. Hunger(Children's Hospital of Philadelphia), Steve Smith(Loxo Oncology at Lilly (United States)), Brian B. Tuch(Loxo Oncology at Lilly (United States))
Cited by 72
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k